Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

被引:485
|
作者
Ronco, LV
Karpova, AY
Vidal, M
Howley, PM [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA
关键词
IRF-3; HPV16; transcription; protein-protein interactions; oncoprotein;
D O I
10.1101/gad.12.13.2061
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferon regulatory factor-3 (IRF-3) was found to specifically interact with HPV16 E6 in a yeast two-hybrid screen. IRF-3 is activated by the presence of double-stranded RNA or by virus infection to form a stable complex with other transcriptional regulators that bind to the regulatory elements of the IFN beta promoter. We show that IRF-3 is a potent transcriptional activator and demonstrate that HPV16 E6 can inhibit its transactivation function. The expression of HPV16 E6 in primary human keratinocytes inhibits the induction of IFN beta mRNA following Sendai virus infection. The binding of HPV16 E6 to IRF-3 does not result in its ubiquitination or degradation. We propose that the interaction of E6 with IRF-3 and the inhibition of IRF-3's transcriptional activity may provide the virus a means to circumvent the normal antiviral response of an HPV16-infected cell.
引用
收藏
页码:2061 / 2072
页数:12
相关论文
共 50 条
  • [1] PKN binds and phosphorylates human papillomavirus E6 oncoprotein
    Gao, QS
    Kumar, A
    Srinivasan, S
    Singh, L
    Mukai, H
    Ono, Y
    Wazer, DE
    Band, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 14824 - 14830
  • [2] The E6 oncoprotein of human papillomavirus 16 as a therapeutic target
    Dymalla, Susanne
    Butz, Karin
    Lohrey, Claudia
    Scheffner, Martin
    Sehr, Peter
    Lewis, Joe
    Hoppe-Seyler, Felix
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3606S - 3606S
  • [3] Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein
    Veldman, T
    Horikawa, I
    Barrett, JC
    Schlegel, R
    JOURNAL OF VIROLOGY, 2001, 75 (09) : 4467 - 4472
  • [4] Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3
    Kumar, A
    Zhao, YT
    Meng, GY
    Zeng, MS
    Srinivasan, S
    Delmolino, LM
    Gao, QS
    Dimri, G
    Weber, GF
    Wazer, DE
    Band, H
    Band, V
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (16) : 5801 - 5812
  • [5] Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides
    Beerheide, W
    Sim, MM
    Tan, YJ
    Bernard, HU
    Ting, AE
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (11) : 2549 - 2560
  • [6] Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein
    Helena Sterlinko Grm
    Paola Massimi
    Noor Gammoh
    Lawrence Banks
    Oncogene, 2005, 24 : 5149 - 5164
  • [7] Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein
    Grm, HS
    Massimi, P
    Gammoh, N
    Banks, L
    ONCOGENE, 2005, 24 (33) : 5149 - 5164
  • [8] The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
    Thompson, DA
    Belinsky, G
    Chang, THT
    Jones, DL
    Schlegel, R
    Münger, K
    ONCOGENE, 1997, 15 (25) : 3025 - 3035
  • [9] The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
    David A Thompson
    Glenn Belinsky
    Ted H-T Chang
    D Leanne Jones
    Robert Schlegel
    Karl Münger
    Oncogene, 1997, 15 : 3025 - 3035
  • [10] Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6
    Peng, SW
    Ji, HX
    Trimble, C
    He, LM
    Tsai, YC
    Yeatermeyer, J
    Boyd, DAK
    Hung, CF
    Wu, TC
    JOURNAL OF VIROLOGY, 2004, 78 (16) : 8468 - 8476